Tag - vaccines-medicine

 
 

VACCINES MEDICINE

Japan Times
JAPAN / FOCUS
Dec 2, 2021
Japan’s drug regulator considers sweeping changes after COVID-19 vaccine delay
After being one of the last major developed nations to approve Pfizer's vaccine, Japan's drug regulator is looking to ease approval requirements for future pandemics.
Japan Times
JAPAN / Science & Health
Nov 30, 2021
Japanese drugmaker Shionogi considers developing vaccine for omicron variant
The company is currently conducting a final clinical trial of its COVID-19 vaccine, aiming to make it available in March.
Japan Times
JAPAN / Science & Health
Nov 18, 2021
Health ministry to allow faster approval of drugs and vaccines in emergencies
The plan, to be finalized by the end of the year, comes amid criticism that Japan lagged other countries in approving drugs and vaccines to deal with the COVID-19 pandemic.
Japan Times
WORLD / ANALYSIS
Nov 9, 2021
COVID-19 pills no substitute for vaccines, disease experts say
Some experts fear the arrival of oral treatments for the coronavirus may further impede vaccination campaigns.
Japan Times
WORLD / Science & Health / ANALYSIS
Nov 6, 2021
Pfizer results open door to new chapter for COVID treatments
The world needs an easy-to-take COVID-19 treatment. Pfizer Inc.'s and Merck & Co. Inc.'s new pills may be just that. But questions remain about their safety and how well they will work.
Japan Times
WORLD / Science & Health
Nov 5, 2021
Pfizer develops COVID-19 pill that cuts hospitalizations and deaths by 89%
The drugmaker claims 'overwhelming efficacy” and plans to submit their findings for emergency authorization as soon as possible.
Japan Times
WORLD / Science & Health
Nov 2, 2021
How often do COVID-19 vaccines cause heart problems in kids?
While the vaccines made by Pfizer-BioNTech and Moderna do seem to be associated with an increased risk of myocarditis, the absolute risk remains very small.
Japan Times
WORLD
Oct 30, 2021
Pfizer won the first round, but Moderna sees final victory ahead
Pfizer has been first across the finish line in nearly every leg of the COVID-19 vaccine race, but Moderna executives say their company's mRNA technology gives it an advantage.
Japan Times
WORLD
Oct 23, 2021
Benefits of Pfizer child shot likely outweigh risks, FDA says
Clearing a vaccine for elementary-school age children would mark a major milestone in the pandemic.
Japan Times
WORLD / Science & Health
Oct 19, 2021
What scientists know about the risk of breakthrough COVID-19 deaths
After former U.S. Secretary of State Colin Powell died Monday from COVID-19 complications, vaccine skeptics immediately seized on news that he had been vaccinated to stoke doubts.
Japan Times
WORLD
Oct 15, 2021
U.S. FDA advisers back Moderna COVID-19 booster shots for older and high-risk people
If the FDA signs off on Moderna's booster, the U.S. Centers for Disease Control and Prevention will make specific recommendations on who should get the shots.
Japan Times
WORLD / FOCUS
Oct 13, 2021
Why some nations using the same vaccines have deadlier COVID-19 outbreaks
Everything from dose intervals to the behavior of unvaccinated people has shaped the outcome of recent delta-driven waves in different countries.
Japan Times
WORLD
Oct 11, 2021
Moderna, racing for profits, keeps COVID-19 vaccine out of reach of poor
Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, a data-tracking firm has said.
Japan Times
WORLD
Oct 8, 2021
Pfizer seeks U.S. COVID-19 vaccine clearance for children age 5 to 11
The Food and Drug Administration has set a date of Oct. 26 for its panel of outside advisers to meet and discuss the application.
Japan Times
JAPAN
Oct 2, 2021
Japan governors demand bolstered medical system as eased COVID-19 curbs stoke concern
The National Governors' Association want sufficient hospital beds, tests and treatments for the coronavirus to be ensured in a draft proposal for the next government.
Japan Times
WORLD / FOCUS
Oct 2, 2021
Nobel Prize in medicine for COVID-19 vaccine? It may be too soon.
Among those seen by other scientists as potential winners are Hungarian-born Katalin Kariko and American Drew Weissman for their work on what are known as messenger ribonucleic acid (mRNA) vaccines.
Japan Times
WORLD
Sep 20, 2021
Pfizer COVID-19 shot safely bolsters antibodies in younger kids
In a trial, two shots of a 10 microgram dose — one-third of the adult shot — produced antibody levels comparable to those seen in a trial of 16- to 25-year-olds who got the adult dose.
Japan Times
JAPAN / FOCUS
Sep 19, 2021
Home COVID-19 care surged as Japan's hospitals filled up, but treatment options were limited
Providing at-home treatment for coronavirus patients presents an entirely different dilemma for the nation's already exhausted medical personnel.
Japan Times
JAPAN / FOCUS
Sep 14, 2021
The hospital conundrum: Why Tokyo’s health system is overflowing with COVID-19 patients
Many hospitals — both those that are private as well as some nationally managed institutions — have been slow to set aside beds for infected patients.
Japan Times
COMMENTARY / World
Sep 8, 2021
Vaccines versus COVID-19: The great immunity debate
...

Longform

Akiko Trush says her experience with the neurological disorder dystonia left her feeling like she wanted to chop her own hand off.
The neurological disorder that 'kills culture'